A. P. Morreale

Erratum to Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model

M. Bounthavong, M. Christopher, R. Kazerooni, 2012, PharmacoEconomics.

Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis

M. Bounthavong, M. Christopher, R. Kazerooni, 2012, PharmacoEconomics.

Association of copayment and socioeconomic status with hormonal contraceptive adherence in a female veteran population.

R. Kazerooni, A. Morreale, A. Takizawa, 2014, Women's health issues : official publication of the Jacobs Institute of Women's Health.

Implementing a comprehensive, 24-hour emergency department pharmacy program.

M. Bounthavong, Helen K Park, Victoria E Aldridge, 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model.

M. Bounthavong, M. Christopher, A. Morreale, 2012, Journal of evaluation in clinical practice.

Probable interaction between warfarin and ginseng.

A. Morreale, Katherine Janetzky, K. Janetzky, 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Therapeutic interchange involving replacement of rofecoxib or celecoxib with valdecoxib.

M. Schaefer, B. K. Plowman, Daniel T Boggie, 2004, American Journal of Health-System Pharmacy.